Physician profile
Benjamin Silver
NPI 1891292553
$590.93
in general payments reported to CMS, 2019-2025
8 companies · $95.61 in 2025
The $95.61 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $192 · 2024: $304 · 2025: $95.61.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $567 · Education: $23.93.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $567.00 |
| Education | $23.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mevion_medical_systems_inc | $171.10 | 2023 | Pts250 |
| Siemens Medical Solutions USA, INC. | $128.00 | 2024 | |
| Teleflex LLC | $95.37 | 2024-2025 | Barrigel |
| Astrazeneca Pharmaceuticals Lp | $79.64 | 2024 | |
| Janssen Biotech, INC. | $52.35 | 2024-2025 | Tremfya |
| Sumitomo Pharma America, INC. | $23.93 | 2024 | Orgovyx |
| Elekta, INC. | $20.71 | 2023 | Elekta Medical Linear Accelerator |
| Abbvie INC. | $19.83 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Silver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.